Mitoxantrone Completed Phase 2 Trials for Myelodysplastic Syndrome / Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00774046High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML